Indian Pharma Co. Can't Revive Claim Over Xifaxan Royalties
An English judge on Friday refused to order an arbitrator to reconsider his award siding with a New Jersey specialty pharmaceutical company in a licensing dispute involving a diarrhea drug, ruling...To view the full article, register now.
Already a subscriber? Click here to view full article